Clinical Trial Update: Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating a dietary supplement version of Anatabloc for Alzheimer's disease has been terminated. The trial was sponsored by Rock Creek Pharmace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Anatabloc

Snippet

Sponsor: Rock Creek Pharmaceuticals, Inc. | Conditions: Alzheimer Disease | Phase 2 | Status: TERMINATED